IPHA · Innate Pharma SA · Webcasts, Transcripts & Audio
$1.38
-0.11 (-7.38%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$154.15M
Shares
111.70M
Volume · Nov 13
17.29K
Avg daily vol (3M)
38.9K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Innate Pharma SA Webcasts
Earnings calls, investor updates, investor days and conferences for Innate Pharma SA (IPHA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-10
Innate Pharma SA (IPHA) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-11-05
Innate Pharma SA (IPHA) Q3 2026 Earnings Call Transcript
Positive tone
Lacutamab clinical and regulatory advancement
IPH4502 Phase 1 data
Monalizumab Phase 3 program
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-09-17
Innate Pharma SA (IPHA) Q2 2026 Earnings Call Transcript
Confident tone
Lacutamab Phase 3 and regulatory path
IPH4502 clinical activity and safety
Monalizumab Phase 3 readout
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-14
Innate Pharma SA (IPHA) September 14, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-13
Innate Pharma SA (IPHA) Q1 2026 Earnings Call Transcript
Confident tone
Catalysts and upcoming milestones
Monalizumab / Pacific 9 Phase 3 NSCLC
AstraZeneca collaboration economics
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
Innate Pharma SA (IPHA) Q4 2025 Earnings Call Transcript
Positive tone
IPH 4502 Nectin-4 ADC
Lacutamab / CTCL development and financing
Monalizumab / AstraZeneca partnership
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Date not confirmed
Innate Pharma SA (IPHA) Q3 2025 Earnings Call Transcript
Confident tone
IPH4502 ADC
Monalizumab PACIFIC-9
Regulatory milestones and FDA interaction
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2025-09-25
Innate Pharma SA (IPHA) September 25, 2025 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q2
2025-06-26
Innate Pharma SA (IPHA) Q2 2025 Earnings Call Transcript
Positive tone
Lacutamab Phase III Plans and Partnering
IPH4502 Nectin-4 ADC Differentiation and Opportunity
IPH4502 Phase I Clinical Progress and Milestones
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Date not confirmed
Innate Pharma SA (IPHA) Q1 2025 Earnings Call Transcript
Positive tone
ADC programs
ANKET NK-Cell Engager platform
Lacutamab partnership and development
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Date not confirmed
Innate Pharma SA (IPHA) Q3 2024 Earnings Call Transcript
Positive tone
IPH4502 Nectin-4 ADC
ANKET NK cell engager platform
Partnership and licensing strategy
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-25
Innate Pharma SA (IPHA) Q2 2024 Earnings Call Transcript
Balanced tone
Lacutamab / TELLOMAK in CTCL
IPH45 / Nectin-4 ADC
Partnerships (Sanofi, AstraZeneca, Takeda)
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
Innate Pharma SA (IPHA) Q1 2024 Earnings Call Transcript
Balanced tone
ADC pipeline expansion
ANKET NK cell engager platform
AstraZeneca partnership and monalizumab
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Innate Pharma SA (IPHA) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Date not confirmed
Innate Pharma SA (IPHA) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-28
Innate Pharma SA (IPHA) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
Innate Pharma SA (IPHA) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Date not confirmed
Innate Pharma SA (IPHA) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Date not confirmed
Innate Pharma SA (IPHA) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-03-24
Innate Pharma SA (IPHA) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-10
Innate Pharma SA (IPHA) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Date not confirmed
Innate Pharma SA (IPHA) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-06-23
Innate Pharma SA (IPHA) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Date not confirmed
Innate Pharma SA (IPHA) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–24 of 24 webcasts